Literature DB >> 11896903

Clinical, laboratory findings and microbiologic characterization of bronchiectasis in Thai patients.

Apirak Palwatwichai1, Chutima Chaoprasong, Anan Vattanathum, Adisorn Wongsa, Anon Jatakanon.   

Abstract

OBJECTIVE: The aim of the present study was to characterize the clinical features, underlying disease states, laboratory findings and microbiological characterization of bronchiectasis in Thai patients.
METHODOLOGY: For a 2-year period all consecutive patients diagnosed with bronchiectasis at Phramongkutklao Hospital, Bangkok, Thailand, were recruited. Data including history, physical examination, underlying disease and laboratory studies were carefully reviewed and recorded.
RESULTS: Fifty patients diagnosed with bronchiectasis were enrolled. Their mean age was 58 years. The most common background aetiology was tuberculosis. Six per cent of the patients were diagnosed as having diffuse panbronchiolitis. Normal chest radiographs were found in 10%. The common organisms isolated were Pseudomonas aeruginosa (20%), Haemophilus influenzae (14%), Klebsiella pneumoniae (14%) and Streptococcus pneumoniae (6%). Non-tuberculous mycobacteria which included Mycobacterium kansasii and Mycobacterium chelonae were found in 6%.
CONCLUSION: We report the characteristics of bronchiectasis in Thai patients. The most common identifiable aetiology was tuberculosis.

Entities:  

Mesh:

Year:  2002        PMID: 11896903     DOI: 10.1046/j.1440-1843.2002.00367.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  17 in total

1.  Pulmonary exacerbations in cystic fibrosis and bronchiectasis.

Authors:  J S Elborn; S C Bell
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

2.  Lobar distribution in non-cystic fibrosis bronchiectasis predicts bacteriologic pathogen treatment.

Authors:  S Izhakian; W G Wasser; L Fuks; B Vainshelboim; B D Fox; O Fruchter; M R Kramer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

3.  Non-tuberculous mycobacteria in patients with bronchiectasis.

Authors:  M Wickremasinghe; L J Ozerovitch; G Davies; T Wodehouse; M V Chadwick; S Abdallah; P Shah; R Wilson
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

Review 4.  Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease.

Authors:  Biswajit Chakrabarti; Peter M A Calverley; Peter D O Davies
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

5.  Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: clinical characteristics and treatment.

Authors:  Blandine Rammaert; Sophie Goyet; Julien Beauté; Sopheak Hem; Vantha Te; Patrich Lorn Try; Charles Mayaud; Laurence Borand; Philippe Buchy; Bertrand Guillard; Sirenda Vong
Journal:  BMC Infect Dis       Date:  2012-01-10       Impact factor: 3.090

6.  Influence of pseudomonas aeruginosa on exacerbation in patients with bronchiectasis.

Authors:  Kiran Chawla; Shashidhar Vishwanath; Mohan K Manu; Bernaitis Lazer
Journal:  J Glob Infect Dis       Date:  2015 Jan-Mar

Review 7.  Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis.

Authors:  Haiqing Chu; Lan Zhao; Heping Xiao; Zhemin Zhang; Jinbo Zhang; Tao Gui; Sugang Gong; Liyun Xu; Xiwen Sun
Journal:  Arch Med Sci       Date:  2014-08-29       Impact factor: 3.318

Review 8.  Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review.

Authors:  Xia-Yi Miao; Xiao-Bin Ji; Hai-Wen Lu; Jia-Wei Yang; Jin-Fu Xu
Journal:  Chin Med J (Engl)       Date:  2015-10-20       Impact factor: 2.628

Review 9.  Global impact of bronchiectasis and cystic fibrosis.

Authors:  Margarida Redondo; Holly Keyt; Raja Dhar; James D Chalmers
Journal:  Breathe (Sheff)       Date:  2016-09

10.  Bacterial colonization and associated factors in patients with bronchiectasis.

Authors:  Sermin Borekci; Ayse Nigar Halis; Gokhan Aygun; Benan Musellim
Journal:  Ann Thorac Med       Date:  2016 Jan-Mar       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.